Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00143910 · ClinicalTrials.gov registry record
Natural History Study of Azathioprine Adherence
A clinical trial of Kidney Transplant, sponsored by Thomas E. Nivens, MD.
- Completed
- Registry status
- 180
- Enrollment target
- 1
- Study location
NCT00143910 is a study of Kidney Transplant that has completed, run by Thomas E. Nivens, MD. The registered enrollment target is 180 participants, below the 1,892-participant average among 30 other Kidney Transplant trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00143910, a study of Kidney Transplant, has completed, sponsored by Thomas E. Nivens, MD.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This study began in 1993 as a prospective, natural history study of renal transplant patients' medication compliance measured by using an electronic monitor on the cap of medication vials. Hypothesis: Poor medication compliance predicts adverse outcomes. Enrollment is closed.
Conditions Studied
Interventions
- OTHER observation
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 1993-04 |
| Est. Completion | 1999-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00143910
The ClinicalTrials.gov registry entry for NCT00143910 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,892-participant average among 30 other Kidney Transplant trials with a reported enrollment target (90% lower). The listed sponsor is Thomas E. Nivens, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Kidney Transplant appearing as the primary indexed condition, and to 1 intervention - of which observation is the first listed.
NCT00143910 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00143910 about?
NCT00143910 is a clinical study titled "Natural History Study of Azathioprine Adherence". This study began in 1993 as a prospective, natural history study of renal transplant patients' medication compliance measured by using an electronic monitor on the cap of medication vials. Hypothesis: Poor medication compliance predicts adverse outcomes. Enrollment is closed.
What is the current status of trial NCT00143910?
This trial is currently completed. The enrollment target is 180 participants. The study started on 1993-04. Estimated completion is 1999-10.
What conditions does trial NCT00143910 study?
This clinical trial studies the following conditions: Kidney Transplant.
What interventions are being tested in trial NCT00143910?
The interventions under investigation include: observation (OTHER).
Who is sponsoring clinical trial NCT00143910?
This trial is sponsored by Thomas E. Nivens, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00143910 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
Social Support Counseling Intervention for Kidney Transplant Candidates
RECRUITING · NA
-
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
RECRUITING · Phase 3
-
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
RECRUITING · Phase 3
-
Advancing Transplantation Outcomes in Children
RECRUITING · Phase 2
-
Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.